| Active principles | Rating | Bibliogr. | Expand |
---|
1 | RNA-Binding Protein FUS | 100 | + | |
2 | Oncogene Proteins, Fusion | 49 | + | |
3 | Cancer Vaccines | 7 | + | |
4 | Antigens, CD11c | 6 | + | |
5 | Lectins, C-Type | 4 | + | |
6 | RNA-Binding Protein EWS | 4 | + | |
7 | Interleukin-12 | 3 | + | |
8 | Proto-Oncogene Protein c-fli-1 | 3 | + | |
9 | Receptors, CCR7 | 3 | + | |
10 | Mannose-Binding Lectins | 3 | + | |
11 | Antigens, CD40 | 3 | + | |
12 | Antigens, CD86 | 3 | + | |
13 | Membrane Glycoproteins | 3 | + | |
14 | Cytokines | 3 | + | |
15 | Interferon-gamma | 2 | + | |
16 | Histocompatibility Antigens Class II | 2 | + | |
17 | Doxorubicin | 2 | + | |
18 | Ovalbumin | 2 | + | |
19 | Toll-Like Receptors | 2 | + | |
20 | Granulocyte-Macrophage Colony-Stimulating Factor | 2 | + | |
21 | Integrin alphaXbeta2 | 2 | + | |
22 | Dioxoles | 2 | + | |
23 | Chemokine CCL21 | 2 | + | |
24 | Ifosfamide | 2 | + | |
25 | Membrane Proteins | 2 | + | |
26 | Programmed Cell Death 1 Ligand 2 Protein | 2 | + | |
27 | Oligodeoxyribonucleotides | 2 | + | |
28 | Integrin alpha Chains | 2 | + | |
29 | gp100 Melanoma Antigen | 2 | + | |
30 | Methylcholanthrene | 2 | + | |
31 | Receptors, Cell Surface | 2 | + | |
32 | Toll-Like Receptor 9 | 2 | + | |
33 | Antigens, CD80 | 1 | + | |
34 | Interleukin-3 Receptor alpha Subunit | 1 | + | |
35 | Toll-Like Receptor 7 | 1 | + | |
36 | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | + | |
37 | Interleukin-12 Subunit p40 | 1 | + | |
38 | Receptors, Interleukin-3 | 1 | + | |
39 | Interleukin-10 | 1 | + | |
40 | HLA-A2 Antigen | 1 | + | |
41 | Tumor Necrosis Factor-alpha | 1 | + | |
42 | Histocompatibility Antigens Class I | 1 | + | |
43 | Neoplasm Proteins | 1 | + | |
44 | Vaccines, DNA | 1 | + | |
45 | Acridine Orange | 1 | + | |
46 | MART-1 Antigen | 1 | + | |
47 | Vaccines | 1 | + | |
48 | Melphalan | 1 | + | |
49 | Interleukin-4 | 1 | + | |
50 | Peptide Fragments | 1 | + | |
51 | Toll-Like Receptor 4 | 1 | + | |
52 | Interleukin-2 | 1 | + | |
53 | Mannose | 1 | + | |
54 | Myeloid Differentiation Factor 88 | 1 | + | |
55 | Chemokine CCL19 | 1 | + | |
56 | Hemocyanin | 1 | + | |
57 | Recombinant Fusion Proteins | 1 | + | |
58 | Toll-Like Receptor 3 | 1 | + | |
59 | Chemokines, CC | 1 | + | |
60 | Dactinomycin | 1 | + | |
61 | CD40 Ligand | 1 | + | |
62 | Recombinant Proteins | 1 | + | |
63 | Antibodies, Monoclonal | 1 | + | |
64 | Antigens, CD274 | 1 | + | |
65 | Peptides | 1 | + | |
66 | Toll-Like Receptor 8 | 1 | + | |
67 | Galactosylceramides | 1 | + | |
68 | Antigens, CD14 | 1 | + | |
69 | Tetrahydroisoquinolines | 1 | + | |
70 | Antigens, CD11b | 1 | + | |
71 | Receptors, Immunologic | 1 | + | |
72 | Receptors, Chemokine | 1 | + | |
73 | Poly I-C | 1 | + | |
74 | HLA-DR Antigens | 1 | + | |
75 | Interferon Type I | 1 | + | |
76 | Chemokines | 1 | + | |
77 | Transcription Factor RelB | 1 | + | |
78 | Mesna | 1 | + | |
79 | Lipopolysaccharides | 1 | + | |
80 | Green Fluorescent Proteins | 1 | + | |
81 | Brefeldin A | 1 | + | |
82 | tat Gene Products, Human Immunodeficiency Virus | 1 | + | |
83 | Repressor Proteins | 1 | + | |
84 | Toll-Like Receptor 2 | 1 | + | |
85 | Forkhead Transcription Factors | 1 | + | |
86 | Receptors, IgG | 1 | + | |
87 | Vaccines, Subunit | 1 | + | |
88 | Cell Extracts | 1 | + | |
89 | HLA-A Antigens | 1 | + | |
90 | Cyclophosphamide | 1 | + | |
91 | Vincristine | 1 | + | |
92 | Monophenol Monooxygenase | 1 | + | |
93 | DNA | 1 | + | |
94 | Chemokine CCL20 | 1 | + | |
95 | Tissue Extracts | 1 | + | |
96 | Receptor, IGF Type 1 | 1 | + | |
97 | Interleukin-17 | 1 | + | |
98 | Egg Proteins | 1 | + | |
99 | RNA, Messenger | 1 | + | |
100 | Immunoglobulin G | 1 | + | |